CytomX Therapeutics Statistics
Total Valuation
CTMX has a market cap or net worth of $46.46 million. The enterprise value is -$40.31 million.
Important Dates
The last earnings date was Thursday, March 6, 2025, after market close.
| Earnings Date | Mar 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CTMX has 80.10 million shares outstanding. The number of shares has increased by 14.82% in one year.
| Current Share Class | 80.10M |
| Shares Outstanding | 80.10M |
| Shares Change (YoY) | +14.82% |
| Shares Change (QoQ) | +0.63% |
| Owned by Insiders (%) | 1.28% |
| Owned by Institutions (%) | 51.97% |
| Float | 73.84M |
Valuation Ratios
The trailing PE ratio is 1.57 and the forward PE ratio is 2.55.
| PE Ratio | 1.57 |
| Forward PE | 2.55 |
| PS Ratio | 0.39 |
| Forward PS | 0.60 |
| PB Ratio | -111.68 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.25
| Current Ratio | 1.25 |
| Quick Ratio | 1.21 |
| Debt / Equity | n/a |
| Debt / EBITDA | 0.31 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 9.69% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 71.91% |
| Revenue Per Employee | $1.14M |
| Profits Per Employee | $263,380 |
| Employee Count | 121 |
| Asset Turnover | 0.86 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CTMX has paid $224,000 in taxes.
| Income Tax | 224,000 |
| Effective Tax Rate | 0.70% |
Stock Price Statistics
The stock price has decreased by -73.39% in the last 52 weeks. The beta is 1.04, so CTMX's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | -73.39% |
| 50-Day Moving Average | 0.73 |
| 200-Day Moving Average | 1.06 |
| Relative Strength Index (RSI) | 37.61 |
| Average Volume (20 Days) | 3,836,349 |
Short Selling Information
The latest short interest is 9.00 million, so 11.24% of the outstanding shares have been sold short.
| Short Interest | 9.00M |
| Short Previous Month | 4.70M |
| Short % of Shares Out | 11.24% |
| Short % of Float | 12.19% |
| Short Ratio (days to cover) | 2.52 |
Income Statement
In the last 12 months, CTMX had revenue of $138.10 million and earned $31.87 million in profits. Earnings per share was $0.38.
| Revenue | 138.10M |
| Gross Profit | 138.10M |
| Operating Income | 25.00M |
| Pretax Income | 15.08M |
| Net Income | 31.87M |
| EBITDA | 26.76M |
| EBIT | 25.00M |
| Earnings Per Share (EPS) | $0.38 |
Full Income StatementBalance Sheet
The company has $100.62 million in cash and $9.39 million in debt, giving a net cash position of $91.24 million or $1.14 per share.
| Cash & Cash Equivalents | 100.62M |
| Total Debt | 9.39M |
| Net Cash | 91.24M |
| Net Cash Per Share | $1.14 |
| Equity (Book Value) | -456,000 |
| Book Value Per Share | -0.01 |
| Working Capital | 21.53M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$86.23 million and capital expenditures -$310,000, giving a free cash flow of -$86.54 million.
| Operating Cash Flow | -86.23M |
| Capital Expenditures | -310,000 |
| Free Cash Flow | -86.54M |
| FCF Per Share | -$1.08 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of 18.10% and 23.08%.
| Gross Margin | 100.00% |
| Operating Margin | 18.10% |
| Pretax Margin | 23.24% |
| Profit Margin | 23.08% |
| EBITDA Margin | 19.38% |
| EBIT Margin | 18.10% |
| FCF Margin | n/a |
Dividends & Yields
CTMX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.82% |
| Shareholder Yield | -14.82% |
| Earnings Yield | 62.58% |
| FCF Yield | -169.93% |
Analyst Forecast
The average price target for CTMX is $5.77, which is 894.83% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.77 |
| Price Target Difference | 894.83% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 1.74% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTMX has an Altman Z-Score of -5.43 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.43 |
| Piotroski F-Score | 4 |